FIJYX
Price
$29.21
Change
+$0.38 (+1.32%)
Updated
Jun 6 closing price
Net Assets
1.28B
JNGLX
Price
$66.24
Change
+$0.63 (+0.96%)
Updated
Jun 6 closing price
Net Assets
4.66B
Interact to see
Advertisement

FIJYX vs JNGLX

Header iconFIJYX vs JNGLX Comparison
Open Charts FIJYX vs JNGLXBanner chart's image
Fidelity Advisor Biotechnology Z
Price$29.21
Change+$0.38 (+1.32%)
VolumeN/A
Net Assets1.28B
Janus Henderson Global Life Sciences D
Price$66.24
Change+$0.63 (+0.96%)
VolumeN/A
Net Assets4.66B
FIJYX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIJYX vs. JNGLX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIJYX is a Buy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.66B vs. FIJYX (1.28B). FIJYX pays higher dividends than JNGLX: FIJYX (3.18) vs JNGLX (0.36). FIJYX was incepted earlier than JNGLX: FIJYX (7 years) vs JNGLX (26 years). JNGLX (0.80) is less costly to investors than FIJYX (0.58). FIJYX is a more actively managed with annual turnover of: 73.00 vs. JNGLX (35.00). FIJYX has a lower initial minimum investment than JNGLX: FIJYX (0) vs JNGLX (2500). FIJYX annual gain was more profitable for investors over the last year : -7.24 vs. JNGLX (-13.11). JNGLX return over 5 years is better than : 8.13 vs. FIJYX (-7.36).
FIJYXJNGLXFIJYX / JNGLX
Total Expense Ratio0.580.8072%
Annual Report Gross Expense Ratio0.580.8072%
Fund Existence7 years26 years-
Gain YTD-3.675-3.358109%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B4.66B27%
Annual Yield % from dividends3.180.36875%
Returns for 1 year-7.24-13.1155%
Returns for 3 years32.118.68370%
Returns for 5 years-7.368.13-91%
Returns for 10 yearsN/A11.80-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SXTC2.090.75
+55.97%
China SXT Pharmaceuticals Inc.
RXRX5.490.92
+20.13%
Recursion Pharmaceuticals
ARVN7.530.61
+8.82%
Arvinas
CHE562.411.63
+0.29%
Chemed Corp
MPU0.87-0.02
-2.14%
Mega Matrix Inc